- Home
- OIS vs ANNX Comparison
OIS vs ANNX Comparison
Compare OIS & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- ANNX
- Stock Information
- Founded
- OIS 1995
- ANNX 2011
- Country
- OIS United States
- ANNX United States
- Employees
- OIS N/A
- ANNX N/A
- Industry
- OIS Metal Fabrications
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- ANNX Health Care
- Exchange
- OIS Nasdaq
- ANNX Nasdaq
- Market Cap
- OIS 352.6M
- ANNX 334.1M
- IPO Year
- OIS 2001
- ANNX 2020
- Fundamental
- Price
- OIS $5.91
- ANNX $4.33
- Analyst Decision
- OIS Hold
- ANNX Strong Buy
- Analyst Count
- OIS 1
- ANNX 4
- Target Price
- OIS $6.50
- ANNX $16.50
- AVG Volume (30 Days)
- OIS 624.3K
- ANNX 3.0M
- Earning Date
- OIS 10-31-2025
- ANNX 11-10-2025
- Dividend Yield
- OIS N/A
- ANNX N/A
- EPS Growth
- OIS N/A
- ANNX N/A
- EPS
- OIS 0.38
- ANNX N/A
- Revenue
- OIS $655,119,000.00
- ANNX N/A
- Revenue This Year
- OIS N/A
- ANNX N/A
- Revenue Next Year
- OIS $6.35
- ANNX N/A
- P/E Ratio
- OIS $15.37
- ANNX N/A
- Revenue Growth
- OIS N/A
- ANNX N/A
- 52 Week Low
- OIS $3.08
- ANNX $1.29
- 52 Week High
- OIS $6.88
- ANNX $5.66
- Technical
- Relative Strength Index (RSI)
- OIS 43.13
- ANNX 73.95
- Support Level
- OIS $6.03
- ANNX $2.54
- Resistance Level
- OIS $6.39
- ANNX $3.03
- Average True Range (ATR)
- OIS 0.29
- ANNX 0.31
- MACD
- OIS -0.06
- ANNX 0.12
- Stochastic Oscillator
- OIS 0.69
- ANNX 68.97
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.